{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:21:39Z","timestamp":1790630499738,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":4877,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1995,3]]},"abstract":"<jats:p>\n                    The urokinase plasminogen activator (uPA) is a proteolytic enzyme which converts the proenzyme plasminogen to the active serine protease plasmin. A cell surface receptor for uPA (uPAR) is attached to the cell membrane by a glycosyl\u2010phosphatidylinositol anchor. Binding of uPA to uPAR leads to an enhanced plasmin formation and thereby an amplification of pericellular proteolysis. We have shown previously that uPAR is expressed on normal blood monocytes and granulocytes, but is deficient on affected blood monocytes and granulocytes in patients with paroxysmal nocturnal haemoglobinuria (PNH), and that uPAR is present in plasma from these patients. In this study a newly established sensitive enzyme\u2010linked immunosorbent assay (ELISA) has been applied for quantttation of uPAR in plasma. Unexpectedly, we found that uPAR is not only present in PNH plasma but also in plasma from healthy individuals. In 39 healthy individuals the mean plasma\u2010uPAR value \u00b1SD was 31 \u00b1 15 p\n                    <jats:sc>m<\/jats:sc>\n                    , median 28 (range 11\u2010108), and the corresponding value for six PNH patients was 116\u00b167 p\n                    <jats:sc>m<\/jats:sc>\n                    , median 90 (range 61\u2010228). The elevated uPAR\u2010level in PNH patients was highly significant (Mann\u2010Whitney test;\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.0001), and may possibly contribute to the propensity for thrombosis in PNH by inhibition of the fibrinolytic system. Binding of pro\u2010uPA by uPAR in plasma may interfere with the appropriate binding of pro\u2010uPA to cell\u2010bound uPAR and therefore inhibit cell\u2010associated plasmin generation and fibrinolysis. It is likely that the uPAR in normal plasma reflects the overall level of activity of the uPAR\u2010mediated cell surface proteolysis. The present ELISA may be used for studies of uPAR levels in plasma from patients with conditions in which this activity might be increased, such as cancer and inflammatory disorders. Future studies will determine if uPAR in plasma is a parameter of clinical importance in these diseases.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.1995.tb08366.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T08:55:52Z","timestamp":1205312152000},"page":"576-581","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria"],"prefix":"10.1111","volume":"89","author":[{"given":"Ebbe","family":"R\u00f8nne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Pappot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gr\u00f8ndahl\u2010Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"H\u00f8yer\u2010Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Plesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Ebbe","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keld","family":"Dan\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.4.742"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/S0021-9258(19)39348-2","article-title":"The human receptor for urokinase plasminogen activator: NH2\u2010terminal amino acid sequence and glycosylation variants","volume":"265","author":"Behrendt N.","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb02235.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.104.4.801"},{"key":"e_1_2_1_6_1","first-page":"239","volume-title":"Proteolysis and Protein Turnover","author":"Dan\u00f8 K.","year":"1993"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00106a001"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1016\/S0021-9258(18)98963-5","article-title":"Plasminogen activation by receptor\u2010bound urokinase: a kinetic study with both cell\u2010associated and isolated receptor","volume":"266","author":"Ellis V.","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb51591.x"},{"key":"e_1_2_1_10_1","volume-title":"Fibrinolysis in Disease","author":"Ellis V.","year":"1994"},{"key":"e_1_2_1_11_1","first-page":"42","article-title":"Sensitive and specific enzyme\u2010linked immunosorbent assay for urokinase\u2010type plasminogen activator and its application to plasma from patients with breast cancer","volume":"111","author":"Gr\u00f8ndahl\u2010Hansen J.","year":"1988","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.115.6.1763"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.98.3.894"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7680492"},{"key":"e_1_2_1_15_1","first-page":"121","article-title":"Increased plasma decay\u2010accelerating factor levels in paroxysmal nocturnal hemoglobinuria","volume":"55","author":"Nakakuma H.","year":"1992","journal-title":"International Journal of Hematology"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/S0021-9258(18)69214-2","article-title":"A 55,000\u201060,000 Mr receptor protein for urokinase\u2010type plasminogen activator: identification in human tumor cell lines and partial purification","volume":"263","author":"Nielsen L.S.","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(90)90149-8"},{"key":"e_1_2_1_18_1","first-page":"4671","article-title":"Prognostic impact of urokinase, urokinase receptor and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue","volume":"54","author":"Pedersen H.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116817"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07803.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.3.808.808"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","unstructured":"Plesner T. Ralfki\u00e6r E. Wittrup M. Johnsen H.E. Pyke C. Pedersen T.L. Hansen N.E.&Dan\u00f8 K.(1994b)Expression of the receptor for urokinase\u2010type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. American Journal of Clinical Pathology (in press).","DOI":"10.1093\/ajcp\/102.6.835"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1002608"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(18)52382-6","article-title":"Cellular receptor for urokinase plasminogen activator: carboxyl\u2010terminal processing and membrane anchoring by glycosyl\u2010phosphatidylinositol","volume":"266","author":"Ploug M.","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1992.tb17200.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.6.1447.1447"},{"key":"e_1_2_1_27_1","first-page":"1059","article-title":"Urokinase\u2010type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas","volume":"138","author":"Pyke C.","year":"1991","journal-title":"American Journal of Pathology"},{"key":"e_1_2_1_28_1","first-page":"1911","article-title":"Receptor for urokinase is present in tumor\u2010associated macrophages in ductal breast carcinoma","volume":"53","author":"Pyke C.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.8.1595.1595"},{"key":"e_1_2_1_30_1","first-page":"201","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"26","author":"Rotoli B.","year":"1989","journal-title":"Seminars in Hematology"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12373187"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(91)81042-7"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(94)90078-7"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00665944"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90782-8"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.2.517"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90250-T"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.100.1.86"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110033251403"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V82.4.1192.1192","article-title":"Complement\u2010induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria","volume":"82","author":"Wiedmaer T.","year":"1993","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.1995.tb08366.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.1995.tb08366.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:35:26Z","timestamp":1698366926000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.1995.tb08366.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["10.1111\/j.1365-2141.1995.tb08366.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.1995.tb08366.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]},"assertion":[{"value":"2008-07-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}